These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 18287971

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Baseline NT-proBNP correlates with change in 6-minute walk distance in patients with pulmonary arterial hypertension in the pivotal inhaled treprostinil study TRIUMPH-1.
    Frantz RP, McDevitt S, Walker S.
    J Heart Lung Transplant; 2012 Aug; 31(8):811-6. PubMed ID: 22759797
    [Abstract] [Full Text] [Related]

  • 5. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH, Handler CE, Akram R, Smith CJ, Das C, Smee J, Nair D, Denton CP, Black CM, Coghlan JG.
    Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
    [Abstract] [Full Text] [Related]

  • 6. NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypertension.
    Souza R, Jardim C, Julio Cesar Fernandes C, Silveira Lapa M, Rabelo R, Humbert M.
    Respir Med; 2007 Jan; 101(1):69-75. PubMed ID: 16781131
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies.
    van Loon RL, Roofthooft MT, Delhaas T, van Osch-Gevers M, ten Harkel AD, Strengers JL, Backx A, Hillege HL, Berger RM.
    Am J Cardiol; 2010 Jul 01; 106(1):117-24. PubMed ID: 20609658
    [Abstract] [Full Text] [Related]

  • 11. N-terminal-pro-B type natriuretic peptide as a useful tool to evaluate pulmonary hypertension and cardiac function in CDH infants.
    Baptista MJ, Rocha G, Clemente F, Azevedo LF, Tibboel D, Leite-Moreira AF, Guimarães H, Areias JC, Correia-Pinto J.
    Neonatology; 2008 Jul 01; 94(1):22-30. PubMed ID: 18160811
    [Abstract] [Full Text] [Related]

  • 12. Continuous hemodynamic monitoring in patients with pulmonary arterial hypertension.
    Frantz RP, Benza RL, Kjellström B, Bourge RC, Barst RJ, Bennett TD, McGoon MD.
    J Heart Lung Transplant; 2008 Jul 01; 27(7):780-8. PubMed ID: 18582809
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Natriuretic peptides and hemodynamics in preeclampsia.
    Tihtonen KM, Kööbi T, Vuolteenaho O, Huhtala HS, Uotila JT.
    Am J Obstet Gynecol; 2007 Apr 01; 196(4):328.e1-7. PubMed ID: 17403408
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D, Flu WJ, Hoeks SE, Galal W, Dunkelgrun M, Boersma E, Kuijper R, van Kuijk JP, Winkel TA, Schouten O, Bax JJ, Poldermans D.
    Anesth Analg; 2009 Nov 01; 109(5):1403-8. PubMed ID: 19843778
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
    Rotondo C, Praino E, Nivuori M, di Serio F, Lapadula G, Iannone F.
    Int J Rheum Dis; 2017 Jan 01; 20(1):90-96. PubMed ID: 26218502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.